Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vinblastine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00226798
What this trial is testing

Immunochemotherapy for Metastatic Renal Cell Carcinoma

Who this might be right for
Adenocarcinoma Clear Cell
Rambam Health Care Campus 45
Early research (Phase 1)Study completedNCT01135563
What this trial is testing

Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours

Who this might be right for
Solid TumorsCentral Nervous System Tumors
The Hospital for Sick Children 14
Large-scale testing (Phase 3)Study completedNCT00059839
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma

Who this might be right for
Lymphoma
Children's Oncology Group 129
Testing effectiveness (Phase 2)Study completedNCT00213278
What this trial is testing

Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma

Who this might be right for
Glioma
The Hospital for Sick Children 50
Testing effectiveness (Phase 2)Looking for participantsNCT06666348
What this trial is testing

Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Who this might be right for
Pediatric Low-grade Glioma
St. Justine's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00079105
What this trial is testing

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

Who this might be right for
Lymphoma
Newcastle-upon-Tyne Hospitals NHS Trust 175
Testing effectiveness (Phase 2)Study completedNCT00086801
What this trial is testing

Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 104
Very early researchLooking for participantsNCT06381570
What this trial is testing

Pilot Study of Vinblastine and Tovorafenib in Pediatric Patients With Recurrent/Progressive RAF Altered Low Grade Gliomas

Who this might be right for
Low-grade Glioma
Daniel Morgenstern 57
Testing effectiveness (Phase 2)Study completedNCT01285817
What this trial is testing

A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.

Who this might be right for
Survival Without Progression
Assistance Publique Hopitaux De Marseille 79
Testing effectiveness (Phase 2)Ended earlyNCT00512980
What this trial is testing

PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne
Testing effectiveness (Phase 2)Ended earlyNCT00505635
What this trial is testing

Biochemotherapy With Temozolomide for Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 5
Early research (Phase 1)Study completedNCT00001570
What this trial is testing

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

Who this might be right for
Kidney NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)UnknownNCT02840409
What this trial is testing

Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)

Who this might be right for
Low Grade Glioma
The Hospital for Sick Children 109
Large-scale testing (Phase 3)Ended earlyNCT00072215
What this trial is testing

Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorTesticular Germ Cell Tumor
Alliance for Clinical Trials in Oncology 1
Testing effectiveness (Phase 2)UnknownNCT00797472
What this trial is testing

Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease

Who this might be right for
Hodgkin's Disease
American Scitech International 120
Testing effectiveness (Phase 2)Looking for participantsNCT06984146
What this trial is testing

Nivo40-AVD for Advanced Classic Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
National Medical Research Radiological Centre of the Ministry of Health of Russia 54
Large-scale testing (Phase 3)Looking for participantsNCT06263231
What this trial is testing

Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Who this might be right for
Sarcoma,Soft Tissue
Intensity Therapeutics, Inc. 333
Large-scale testing (Phase 3)Study completedNCT00002495
What this trial is testing

SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease

Who this might be right for
Lymphoma
SWOG Cancer Research Network 348
Early research (Phase 1)Study completedNCT00001302
What this trial is testing

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Who this might be right for
Breast CancerKidney NeoplasmLymphoma+2 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)UnknownNCT00003181
What this trial is testing

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Hope Cancer Institute, Inc. 35
Next Page